USPTO serial 79357618
Reviewed by CopyMark Law Group
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Software; software and applications for mobile devices; downloadable software applications; specialized software; collaborative software; data communication software; file sharing software; document management software; software for management of data and files and for databases; process control software; data processing software; product lifecycle management software; industrial process management software; software for production process monitoring, analysis, control and operation; software for verification of the regulatory compliance of goods; software for monitoring the regulatory compliance of clinical trials; software for quality control in the field of medical devices and the pharmaceutical industry; software for use in the pharmaceutical and medical device industry for monitoring, analysis, control and operation of the regulatory compliance of manufacturing processes and clinical trials | ACTIVE | — |
| 038 | Providing access to and rental of access time to a database; providing access to data or documents in electronic format on centralized files for remote consultation; providing access to platforms and portals on the Internet; electronic transmission of messages, data and documents | ACTIVE | — |
| 042 | Hosting services and software as a service and rental of software; development, programming and implementation of software; development, programming and implementation of data processing software; development, programming and implementation of software for checking the regulatory compliance of goods; development, programming and implementation of software for quality control of goods and clinical studies; accreditation services (certification of skills and quality) in the field of medical devices and the pharmaceutical industry; certification (quality control); quality control consultation; analysis and assessment of product design in the field of medical devices and the pharmaceutical industry; qualitative assessment of the performance of pharmaceuticals, medical products and medical devices; providing information on product development; preliminary assessment services in the field of new pharmaceuticals, medical products and medical devices; pharmaceutical research and development consultation services; consultation services on product development in the field of medical devices and the pharmaceutical industry; providing information on the results of clinical trials for pharmaceuticals, medical products and medical devices; design and development of medical technologies; design and development of analytical methods and tests; research and development services in the field of medical devices and pharmaceuticals; scientific and technological design services; conducting of scientific feasibility studies; carrying out technical feasibility studies; feasibility studies with respect to product design; feasibility studies with respect to analysis of materials; feasibility studies with respect to clinical trials; planning and conducting preclinical and clinical studies; providing medical and scientific research information of pharmaceuticals and clinical trials; conducting clinical trials for third parties (scientific research); conducting clinical trials for pharmaceuticals, medical products and medical apparatus; conducting of clinical studies; scientific research; medical research; pharmaceutical research and development; study of technical projects in the field of medical devices and the pharmaceutical industry; assessment of chemical information in relation to risks; assessment of toxicological information in relation to risks; risk assessment in the field of medical devices and the pharmaceutical industry; scientific assessment of risks; analytical laboratory services; laboratory research services relating to pharmaceuticals, medical devices and medical products; scientific laboratory services; advisory services with respect to laboratory tests; scientific diagnostic test services | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 3, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 15, 2025 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 21, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 21, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 11, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 15, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 15, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 20, 2024 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 20, 2024 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 20, 2024 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 29, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 7, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 7, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 1, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 1, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 30, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 26, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 23, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 19, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 16, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |